Roswell clinic says it received drug in fed probe
ROSWELL, N.M. (AP) – A New Mexico health clinic has confirmed that some patients may have received possibly tainted anti-inflammatory injections prepared by a compounding manufacturer in Tennessee.
The Roswell Daily Record reports (http://bit.ly/18B5rbY) that Roswell Family Care said this week that around 50 patients received an injectable steroid involved in a U.S. Food and Drug Administration investigation.
Methylprednisolone acetate (MPA) is used to treat inflammation, asthma, joint and upper respiratory issues. It is suspected of killing at least 55 people last year following an outbreak of fungal meningitis.
The Roswell clinic’s nurse practitioner David Aguilar says so far there are no cases of infection or reactions in New Mexico.
Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states.
